Stay updated with breaking news from Value pathway. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The CMS Innovation Center's Strategy To Support Person-Centered, Value-Based Specialty Care: 2024 Update healthaffairs.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healthaffairs.org Daily Mail and Mail on Sunday newspapers.
The American College of Rheumatology praised several aspects of a 2022 Medicare physician fee schedule proposed rule, including evaluation and management coding changes and the promise of greater telehealth flexibility. The ACR issued its statement days after submitting formal comments to CMS regarding the proposed rule. According to the group, rheumatology leaders are “encouraged” by ....
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and analyses; and other health policy news. Week in Review Highlight of the Week: On Wednesday, HHS finalized its review of Phase 3 Provider Relief Fund applications and began distribution of the funds. Read more about this action and other news below. I. Regulations, Notices & Guidance On December 14, 2020, the Department of Health and Human Services (HHS), along with several other agencies, issued a final rule entitled, Equal Participation of Faith-Based Organizations in the Federal Agencies’ Programs and Activities. This rule provides clarity about the rights and obligations of faith-based organizations participating in the Agencies’ Federal financial assistance programs and activities. This rulemaking is intended to ensure tha ....
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and analyses; and other health policy news. Week in Review Highlight of the Week: This week, HHS issued a final rule intended to govern the administrative dispute process in the 340B Drug Pricing Program. Read more about the rule and other news below. I. Regulations, Notices & Guidance On December 8, 2020, the Food & Drug Administration (FDA) issued guidance entitled, Best Practices in Developing Proprietary Names for Human Nonprescription Drug Products. This draft guidance describes best practices to help minimize medication errors and otherwise avoid adoption of proprietary names that contribute to violations of the Federal Food, Drug, and Cosmetic Act (FD&C Act) and its implementing regulations. The draft guidance also describes the ....